Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

7.1%

5 terminated/withdrawn out of 70 trials

Success Rate

88.1%

+1.6% vs industry average

Late-Stage Pipeline

14%

10 trials in Phase 3/4

Results Transparency

11%

4 of 37 completed trials have results

Key Signals

11 recruiting4 with results

Enrollment Performance

Analytics

Phase 2
23(38.3%)
N/A
17(28.3%)
Phase 1
9(15.0%)
Phase 4
6(10.0%)
Phase 3
4(6.7%)
Early Phase 1
1(1.7%)
60Total
Phase 2(23)
N/A(17)
Phase 1(9)
Phase 4(6)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (70)

Showing 20 of 70 trials
NCT07019493Recruiting

Young Stroke Service Deep Phenotyping: Exploring Recovery in Young Adult Survivors of Stroke

Role: collaborator

NCT07535580Not ApplicableCompleted

Patient-Reported Stent Symptom Outcomes and Migration Rates Following Modified Single-J Ureteric Stent Insertion After Ureteroscopy

Role: lead

NCT04075305Recruiting

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

Role: collaborator

NCT07225465Phase 2Not Yet Recruiting

Evaluating Safe Ketone Thresholds To Minimise Ketosis in People With Type 1 Diabetes Using Dapagliflozin

Role: collaborator

NCT07017686Not ApplicableRecruiting

The Reboot Study: A Safety Study of Abdominal Vagus Nerve Stimulation for Moderate to Severe Drug Refractory Rheumatoid Arthritis

Role: collaborator

NCT05788081Phase 2Active Not Recruiting

Treatment Of Newly-diagnosed Follicular Lymphoma With CELMoD Golcadomide, Rituximab +/- Nivolumab.

Role: collaborator

NCT05899985Not ApplicableRecruiting

Magnetic Sentinel Lymph Node Mapping in Upper Gastro-Intestinal Cancer: A Feasibility Clinical Investigation

Role: collaborator

NCT06871254Not ApplicableRecruiting

Spinal Cord Injury Neurorecovery Collaboration

Role: collaborator

NCT07079007Not Yet Recruiting

Use of Water Ingestion in Small Intestine Ultrasound

Role: lead

NCT06916819Not ApplicableRecruiting

Food Challenge at Home or in Medical Practice - the FoodCHOMP Study

Role: lead

NCT04962126Phase 2Active Not Recruiting

Frontline Treatment of Follicular Lymphoma With AtezolizUmab and Obinutuzumab With and Without RadiOtherapy

Role: collaborator

NCT02770040Phase 4Completed

Optimising Infliximab Induction Therapy for Acute Severe Ulcerative Colitis

Role: lead

NCT06279260Recruiting

National Robotics-Assisted Radical Prostatectomy Database

Role: collaborator

NCT05169177Recruiting

Radio-opaque Contrast Agents for Liver Cancer Targeting With KIM During Radiation Therapy

Role: collaborator

NCT03244176Early Phase 1Active Not Recruiting

Feasibility Study of Induction and Maintenance Avelumab Plus R-CHOP in Patients With Diffuse DLBCL: The AvR-CHOP Study

Role: lead

NCT05184790Recruiting

LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology

Role: collaborator

NCT03610061Phase 1Completed

A Trial of Radiotherapy and Durvalumab in DLBCL and FL

Role: lead

NCT04901234Phase 2Recruiting

Adaptive RadioTherapy for OroPharynx Cancer

Role: collaborator

NCT05182931Phase 2Unknown

A Prospective, Multi-Centre Trial of TKI Redifferentiation Therapy in Patients With RAIR Thyroid Cancer (I-FIRST Study)

Role: collaborator

NCT04127981Not ApplicableUnknown

Medical Imaging of Cachexia

Role: collaborator